Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma

BackgroundHead and neck squamous cell carcinoma (HNSCC) is currently the eighth leading cause of cancer death worldwide. The often severe side effects, functional impairments and unfavorable cosmetic outcome of conventional therapies for HNSCC have prompted the quest for novel treatment strategies, including the evaluation of nanotechnology to improve e.g. drug delivery and cancer imaging. Although silica nanoparticles hold great promise for biomedical applications, they have not yet been investigated in the context of HNSCC. In the present in-vitro study we thus analyzed the cytotoxicity, uptake and intracellular fate of 200-300 nm core-shell silica nanoparticles encapsulating fluorescent dye tris(bipyridine)ruthenium(II) dichloride with hydroxyl-, aminopropyl- or PEGylated surface modifications (Ru@SiO2-OH, Ru@SiO2-NH2, Ru@SiO2-PEG) in the human HNSCC cell line UMB-SCC 745.ResultsWe found that at concentrations of 0.125 mg/ml, none of the nanoparticles used had a statistically significant effect on proliferation rates of UMB-SCC 745. Confocal and transmission electron microscopy showed an intracellular appearance of Ru@SiO2-OH and Ru@SiO2-NH2 within 30 min. They were internalized both as single nanoparticles (presumably via clathrin-coated pits) or in clusters and always localized to cytoplasmic membrane-bounded vesicles. Immunocytochemical co-localization studies indicated that only a fraction of these nanoparticles were transferred to early endosomes, while the majority accumulated in large organelles. Ru@SiO2-OH and Ru@SiO2-NH2 nanoparticles had never been observed to traffic to the lysosomal compartment and were rather propagated at cell division. Intracellular persistence of Ru@SiO2-OH and Ru@SiO2-NH2 was thus traceable over 5 cell passages, but did not result in apparent changes in cell morphology and vitality. In contrast to Ru@SiO2-OH and Ru@SiO2-NH2 uptake of Ru@SiO2-PEG was minimal even after 24 h.ConclusionsOur study is the first to provide evidence that silica-based nanoparticles may serve as useful tools for the development of novel treatment options in HNSCC. Their long intracellular persistence could be of advantage for e.g. chronic therapeutic modalities. However, their complex endocytotic pathways require further investigations.

[1]  María Vallet-Regí,et al.  Drug delivery from ordered mesoporous matrices , 2009, Expert opinion on drug delivery.

[2]  Min Chen,et al.  Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. , 2005, Experimental cell research.

[3]  Deng-Fwu Hwang,et al.  In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. , 2007, Environmental science & technology.

[4]  W. Ahrens,et al.  Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe. , 2010, European journal of cancer.

[5]  Yinfa Ma,et al.  Study of uptake and loss of silica nanoparticles in living human lung epithelial cells at single cell level , 2009, Analytical and bioanalytical chemistry.

[6]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles for intracellular controlled drug delivery. , 2010, Small.

[7]  P. Rubin,et al.  Cancer of the head and neck. , 1972, JAMA.

[8]  J B Vermorken,et al.  Optimal treatment for recurrent/metastatic head and neck cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Dominique Lison,et al.  The nanosilica hazard: another variable entity , 2010, Particle and Fibre Toxicology.

[10]  Richard C Zangar,et al.  Cellular recognition and trafficking of amorphous silica nanoparticles by macrophage scavenger receptor A , 2011, Nanotoxicology.

[11]  Ande Bao,et al.  In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. , 2010, International journal of pharmaceutics.

[12]  Alda Pinto,et al.  USPIO‐enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer , 2006, Journal of magnetic resonance imaging : JMRI.

[13]  P. Moghe,et al.  PEG-variant biomaterials as selectively adhesive protein templates: model surfaces for controlled cell adhesion and migration. , 2000, Biomaterials.

[14]  Chung-Yuan Mou,et al.  The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. , 2007, Biomaterials.

[15]  C. Housecroft,et al.  Controlling silica nanoparticle properties for biomedical applications through surface modification , 2008 .

[16]  Liang Zhou,et al.  In-vitro evaluation of paclitaxel-loaded MPEG–PLGA nanoparticles on laryngeal cancer cells , 2009, Anti-cancer drugs.

[17]  S. Kwan,et al.  Diagnostic delays in head and neck cancers. , 1999, European journal of cancer care.

[18]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[19]  A. Jacquier,et al.  [Cervical lymph nodes]. , 2008, Journal de radiologie.

[20]  F. Garbagnati,et al.  Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx. , 2007, Journal of vascular and interventional radiology : JVIR.

[21]  T. Bein,et al.  Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol) , 2010 .

[22]  J. Zou,et al.  Inhibition of ataxia-telangiectasia mutated by antisense oligonucleotide nanoparticles induces radiosensitization of head and neck squamous-cell carcinoma in mice. , 2009, Cancer biotherapy & radiopharmaceuticals.

[23]  John A Kalef-Ezra,et al.  Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma , 2010, Physics in medicine and biology.

[24]  P. Harrison,et al.  Profiling early head and neck cancer , 2005, Nature Reviews Cancer.

[25]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[26]  Min Zhu,et al.  The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid , 2010 .

[27]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[28]  Iqbal Ahmad,et al.  Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. , 2010, Toxicology.

[29]  Wenwan Zhong,et al.  Nanomaterials in fluorescence-based biosensing , 2009, Analytical and bioanalytical chemistry.

[30]  A. Forastiere,et al.  Head and neck cancer: changing epidemiology, diagnosis, and treatment. , 2008, Mayo Clinic proceedings.

[31]  Jinming Gao,et al.  Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[32]  Katrina M. Smith,et al.  Components of socioeconomic risk associated with head and neck cancer: a population-based case-control study in Scotland. , 2010, The British journal of oral & maxillofacial surgery.

[33]  Chung-Yuan Mou,et al.  Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. , 2007, Nano letters.

[34]  J. Tobias.  Current Issues in Cancer: Cancer of the head and neck , 1994, BMJ.

[35]  Raoul Kopelman,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer. , 2008, Nano letters.

[36]  Mukund Seshadri,et al.  Combined magnetic resonance and optical imaging of head and neck tumor xenografts using Gadolinium-labelled phosphorescent polymeric nanomicelles , 2010, Head & neck oncology.

[37]  Ronghua Yang,et al.  Nucleic acid conjugated nanomaterials for enhanced molecular recognition. , 2009, ACS nano.

[38]  Wei Wang,et al.  Toxicity of amorphous silica nanoparticles in mouse keratinocytes , 2009 .

[39]  Christoph Alexiou,et al.  Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. , 2003, Journal of drug targeting.

[40]  M. Maynadier,et al.  Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy. , 2010, International journal of pharmaceutics.

[41]  T. Boulikas.  Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin , 2009, Expert opinion on investigational drugs.

[42]  Xiao-Dong Zhou,et al.  In vitro toxicity of silica nanoparticles in human lung cancer cells. , 2006, Toxicology and applied pharmacology.

[43]  Xiaohua Huang,et al.  Effect of Plasmonic Gold Nanoparticles on Benign and Malignant Cellular Autofluorescence: A Novel Probe for Fluorescence Based Detection of Cancer , 2007, Technology in cancer research & treatment.

[44]  Uwe Pieles,et al.  Assessment of uptake and toxicity of fluorescent silica nanoparticles in zebrafish (Danio rerio) early life stages. , 2010, Aquatic toxicology.

[45]  F. Berrino,et al.  Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group. , 1998, European journal of cancer.

[46]  Dong Chen,et al.  The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.

[47]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[48]  J. Barton,et al.  Fluorescein redirects a ruthenium-octaarginine conjugate to the nucleus. , 2009, Journal of the American Chemical Society.

[49]  Mark E. Davis,et al.  Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. , 2007, Bioconjugate chemistry.

[50]  Martin Fussenegger,et al.  Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. , 2003, Biotechnology and bioengineering.

[51]  S. Bishnoi,et al.  Rapid Raman imaging of stable, functionalized nanoshells in mammalian cell cultures. , 2009, Nano letters.

[52]  Chung-Yuan Mou,et al.  Well-Ordered Mesoporous Silica Nanoparticles as Cell Markers , 2005 .

[53]  A. Bao,et al.  Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide. , 2009, Journal of vascular and interventional radiology : JVIR.

[54]  Joachim P Spatz,et al.  Protein repellent properties of covalently attached PEG coatings on nanostructured SiO(2)-based interfaces. , 2007, Biomaterials.

[55]  T. Asefa,et al.  Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. , 2009, Chemical research in toxicology.

[56]  Jin-Ho Choy,et al.  Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. , 2009, Journal of inorganic biochemistry.

[57]  Chung-Yuan Mou,et al.  Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. , 2008, Small.

[58]  G. Lucignani.  Nanoparticles for concurrent multimodality imaging and therapy: The dawn of new theragnostic synergies , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[59]  Andreas Neubauer,et al.  Treatment of HNSCC cell lines with the EGFR‐specific inhibitor cetuximab (Erbitux®) results in paradox phosphorylation of tyrosine 1173 in the receptor , 2006, FEBS letters.

[60]  Xinglu Huang,et al.  The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species. , 2010, Biomaterials.

[61]  Y. Yoshioka,et al.  Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. , 2010, Die Pharmazie.